These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29884816)

  • 1. Identification of serpins specific for activated protein C using a lysate-based screening assay.
    Polderdijk SGI; Huntington JA
    Sci Rep; 2018 Jun; 8(1):8793. PubMed ID: 29884816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel recombinant serpin with potential antithrombotic properties.
    Hopkins PC; Crowther DC; Carrell RW; Stone SR
    J Biol Chem; 1995 May; 270(20):11866-71. PubMed ID: 7744836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin.
    Glasscock LN; Gerlitz B; Cooper ST; Grinnell BW; Church FC
    Biochim Biophys Acta; 2003 Jun; 1649(1):106-17. PubMed ID: 12818196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracking structural features leading to resistance of activated protein C to alpha 1-antitrypsin.
    Shen L; Dahlbäck B; Villoutreix BO
    Biochemistry; 2000 Mar; 39(11):2853-60. PubMed ID: 10715104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and characterization of an APC-specific serpin for the treatment of hemophilia.
    Polderdijk SG; Adams TE; Ivanciu L; Camire RM; Baglin TP; Huntington JA
    Blood; 2017 Jan; 129(1):105-113. PubMed ID: 27789479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
    Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
    Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonenzymatic anticoagulant activity of the mutant serine protease Ser360Ala-activated protein C mediated by factor Va.
    Gale AJ; Sun X; Heeb MJ; Griffin JH
    Protein Sci; 1997 Jan; 6(1):132-40. PubMed ID: 9007985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V and protein S as cofactors to activated protein C.
    Dahlbäck B
    Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C.
    Gale AJ; Tsavaler A; Griffin JH
    J Biol Chem; 2002 Aug; 277(32):28836-40. PubMed ID: 12063259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of serpin specificity: cooperative interactions in the reactive-site loop sequence of antithrombin specifically restrict the inhibition of activated protein C.
    Hopkins PC; Pike RN; Stone SR
    J Mol Evol; 2000 Nov; 51(5):507-15. PubMed ID: 11080374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zinc ions bind to and inhibit activated protein C.
    Zhu T; Ubhayasekera W; Nickolaus N; Sun W; Tingsborg S; Mowbray SL; Schedin-Weiss S
    Thromb Haemost; 2010 Sep; 104(3):544-53. PubMed ID: 20664913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel exosite in the light chain of human activated protein C essential for interaction with blood coagulation factor Va.
    Mesters RM; Heeb MJ; Griffin JH
    Biochemistry; 1993 Nov; 32(47):12656-63. PubMed ID: 8251484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosite-dependent regulation of the protein C anticoagulant pathway.
    Rezaie AR
    Trends Cardiovasc Med; 2003 Jan; 13(1):8-15. PubMed ID: 12554095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the P2 residue in determining the specificity of serpins.
    Djie MZ; Le Bonniec BF; Hopkins PC; Hipler K; Stone SR
    Biochemistry; 1996 Sep; 35(35):11461-9. PubMed ID: 8784202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique serpin P1' glutamate and a conserved β-sheet C arginine are key residues for activity, protease recognition and stability of serpinA12 (vaspin).
    Ulbricht D; Pippel J; Schultz S; Meier R; Sträter N; Heiker JT
    Biochem J; 2015 Sep; 470(3):357-67. PubMed ID: 26199422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic cofactor function of factor V and protein S to activated protein C in the inactivation of the factor VIIIa - factor IXa complex -- species specific interactions of components of the protein C anticoagulant system.
    Shen L; He X; Dahlbäck B
    Thromb Haemost; 1997 Sep; 78(3):1030-6. PubMed ID: 9308749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The appended tail region of heparin cofactor II and additional reactive centre loop mutations combine to increase the reactivity and specificity of alpha1-proteinase inhibitor M358R for thrombin.
    Sutherland JS; Bhakta V; Sheffield WP
    Thromb Haemost; 2007 Nov; 98(5):1014-23. PubMed ID: 18000606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering the proteolytic specificity of activated protein C improves its pharmacological properties.
    Berg DT; Gerlitz B; Shang J; Smith T; Santa P; Richardson MA; Kurz KD; Grinnell BW; Mace K; Jones BE
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4423-8. PubMed ID: 12671072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity and reactive loop length requirements for crmA inhibition of serine proteases.
    Tesch LD; Raghavendra MP; Bedsted-Faarvang T; Gettins PG; Olson ST
    Protein Sci; 2005 Feb; 14(2):533-42. PubMed ID: 15632287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and energetic characteristics of the heparin-binding site in antithrombotic protein C.
    Friedrich U; Blom AM; Dahlbäck B; Villoutreix BO
    J Biol Chem; 2001 Jun; 276(26):24122-8. PubMed ID: 11316800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.